Asrazid T 250mg/31.25mg Injection
Marketer
Asrawell Lifecare
Salt Composition
Ceftazidime (250mg) + Tazobactum (31.25mg)
Overview Asrazid T 250mg/31.25mg Injection
Asrazid T 250mg/31.25mg injectable solution is a dual-action antibiotic. It's indicated for a range of bacterial infections, combating microbes to halt their proliferation and infection spread. Administration of Asrazid T 250mg/31.25mg Injection requires strict medical oversight. Consistent adherence to the prescribed schedule is crucial; the treatment course must be completed regardless of symptom improvement. Premature cessation may compromise its effectiveness. Common adverse reactions include nausea, vomiting, diarrhea, and dyspepsia. Report worsening side effects promptly to your physician. Seek immediate medical attention for allergic reactions (skin rashes, pruritus, edema, respiratory distress). Disclose all current medications to your doctor before commencing treatment. Expectant and nursing mothers should consult their physician. Alcohol consumption should be avoided due to the risk of increased somnolence. While generally non-impairing to driving ability, refrain from driving if drowsiness or dizziness occurs. Adequate rest, nutritious food, and sufficient hydration are recommended for optimal recovery. Your doctor may order laboratory and imaging tests to monitor the treatment's efficacy.
Primary Ingredients of Asrazid T 250mg/31.25mg Injection
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Asrazid T 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Asrazid T 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is not permitted.
Common Side effects of Asrazid T 250mg/31.25mg Injection:
- Nausea
- Vomiting
- Diarrhea
- Stomach pain
- Increased liver enzymes
- Allergic reaction
How to use Asrazid T 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Asrazid T 250mg/31.25mg Injection works:
Asrazid T Injection (250mg Ceftazidime/31.25mg Tazobactum) unites a cephalosporin antibiotic, Ceftazidime, with the beta-lactamase inhibitor, Tazobactum. Ceftazidime's antibacterial action disrupts bacterial cell wall synthesis, hindering their ability to thrive. Tazobactum counteracts bacterial resistance mechanisms, thereby optimizing Ceftazidime's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions from concurrent use of Asrazid T 250mg/31.25mg Injection and alcohol.
PregnancySAFE IF PRESCRIBED
The injectable medication Asrazid T 250mg/31.25mg is usually deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; nevertheless, clinical data from human trials remain scarce.
Breast feedingSAFE IF PRESCRIBED
Asrazid T 250mg/31.25mg injections pose minimal risk during lactation. Research in humans indicates negligible drug transfer to breast milk, thereby minimizing potential harm to the infant.
DrivingUNSAFE
The injection Asrazid T 250mg/31.25mg can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with impaired kidney function should receive Asrazid T 250mg/31.25mg Injection with careful monitoring. Dosage modification for Asrazid T 250mg/31.25mg Injection may be necessary; physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should exercise caution when using Asrazid T 250mg/31.25mg Injection. Dosage modification of Asrazid T 250mg/31.25mg Injection may be necessary. Physician consultation is advised.
What if you forget to take Asrazid T 250mg/31.25mg Injection :
Should you inadvertently skip a scheduled Asrazid T 250mg/31.25mg Injection, seek medical advice.
Facts to Know About Asrazid T 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Type of Medication | Agents against infection |
3,018 People bought this recently